72
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy

, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 2623-2631 | Published online: 18 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Trang Thanh Pham, Stephanie Lim & Michael Lin. (2022) Predicting neoadjuvant chemoradiotherapy response with functional imaging and liquid biomarkers in locally advanced rectal cancer. Expert Review of Anticancer Therapy 22:10, pages 1081-1098.
Read now

Articles from other publishers (4)

Joao Victor Machado Carvalho, Valérie Dutoit, Claudia Corrò & Thibaud Koessler. (2023) Promises and Challenges of Predictive Blood Biomarkers for Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy. Cells 12:3, pages 413.
Crossref
Chen Chen, Wei Yi, Zhi-fan Zeng, Qiao-xuan Wang, Wu Jiang, Yuan-hong Gao & Hui Chang. (2022) Serum apolipoprotein B to apolipoprotein A-I ratio is an independent predictor of liver metastasis from locally advanced rectal cancer in patients receiving neoadjuvant chemoradiotherapy plus surgery. BMC Cancer 22:1.
Crossref
Yingcheng He, Jianrui Chen, Yanbing Ma & Hongping Chen. (2022) Apolipoproteins: New players in cancers. Frontiers in Pharmacology 13.
Crossref
María del Pilar Chantada-Vázquez, Mercedes Conde-Amboage, Lucía Graña-López, Sergio Vázquez-Estévez, Susana B. Bravo & Cristina Núñez. (2022) Circulating Proteins Associated with Response and Resistance to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancers 14:4, pages 1087.
Crossref